Download the brochure Health & Wellbeing
Get it
C5KH

Health & Wellbeing

UCITS ETF
Holdings 72
Expense ratio 0.49%
Ticker C5KH
ISIN IE0001EY64U4

Fund Vision

The CIRCA5000 Health & Wellbeing UCITS ETF (C5KH) aims to ensure the world’s population has access to the health-related goods and services needed to live a healthful life. Access to healthcare services across and within countries varies significantly. Life expectancy globally is far from equal — there is a 30-year gap between Japan (85 years) and Lesotho (55 years). At least half of the world’s population does not have access to essential health services without being forced into financial poverty (WHO). The investee companies within C5KH aim to improve health impacts for people worldwide. C5KH aims to deliver investment results corresponding to the impak CIRCA5000 Health & Wellbeing Impact Index.

As at 24/04/2024

Sub-theme Breakdown

Check out the specific areas of growth and innovation that this fund targets.

  1. Health 65.3%
  2. Housing 22.6%
  3. Sanitation 6.8%
  4. Nutrition 4.0%
  5. Care 1.3%

Positive Impact

We use external specialists to provide investment-grade data on the social and environmental outcomes of the companies within our funds.

  • 107M Patients Treated
  • 307K Lives Extended
  • 120k Cumulative affordable houses built or restored

CIRCA5000's strategy is to invest in companies that manufacture products, or offer the services that generate a positive environmental or social impact. For example, the homeowner who buys solar panels for their home is ultimately responsible for the positive impact generated and the company that manufactured them is the facilitator. Therefore, by investing in these companies, CIRCA5000 supports users to generate a positive impact, but we are of course, not responsible for it on our own.

This impact is therefore 'associated' rather than direct. We source our data from two providers, Net Purpose and impak Analytics, to ensure we have the most robust and complete data possible.

Data is annual and based on the latest company reports, with some additional products and services estimates provided by Net Purpose.

As at 23/04/2024

Index Performance

Past performance is not a reliable indicator of future performance. The figures in the chart above refer to simulated past performance from the Impak CIRCA5000 Health & Wellbeing Impact Index (ICHWII) established by BITA (www.bitadata.com). It is calculated using backtested performance data from the underlying holdings of the CIRCA5000 Health & Wellbeing UCITS ETF (C5KH) and the data is backtested from 07/09/2012. The performance is backtested index data which has been sourced from the index provider bitadata and is based on what they perceive to be reasonable assumptions and objective data. The index currency is based in USD and gross of fees. Factors such as fund fees, trading fees and currency exchange rates may affect your return. The annual TER for C5KH is 0.49%.

As at 24/04/2024

Fund Holdings

Download spreadsheet
Name
HDFC Bank Ltd
7.2%
439 /1,000
Stryker
5.7%
389 /1,000
Elevance Health Inc
4.1%
247 /1,000
Agilent Technologies
3.6%
393 /1,000
Molina Healthcare, Inc.
3.3%
559 /1,000
Biogen
3.1%
455 /1,000
Danaher
3.1%
201 /1,000
Sonova Holding AG
2.6%
583 /1,000
Astellas Pharma Inc.
2.5%
494 /1,000
Baxter
2.3%
384 /1,000
Swedish Orphan Biovitrum
2.2%
592 /1,000
Vonovia SE
2.1%
344 /1,000
Fresenius SE & Co KGaA
2.0%
421 /1,000
Ultragenyx Pharma
2.0%
617 /1,000
Eurofins Scientific
1.9%
388 /1,000
Genmab
1.9%
336 /1,000
Hologic Inc
1.9%
329 /1,000
Convatec
1.8%
410 /1,000
Pentair
1.7%
357 /1,000
United Therapeutics Corp
1.7%
380 /1,000
Recordati
1.7%
431 /1,000
Sun Communities Inc.
1.6%
344 /1,000
American Water Works Company
1.6%
254 /1,000
Getinge AB
1.6%
403 /1,000
Bouygues S.A.
1.6%
390 /1,000
Xior Student Housing
1.6%
455 /1,000
Rexnord Corp
1.5%
398 /1,000
Halma
1.5%
361 /1,000
HealthEquity, Inc.
1.5%
373 /1,000
Biomerieux
1.5%
398 /1,000
Symrise
1.4%
278 /1,000
Dr. Reddy's Laboratories Ltd
1.4%
350 /1,000
Cavco Industries Inc
1.4%
388 /1,000
Exact Sciences Corp
1.4%
295 /1,000
LEG Immobilien
1.4%
332 /1,000
Hikma Pharmaceuticals
1.3%
380 /1,000
Elekta AB (publ)
1.3%
373 /1,000
Cochlear Ltd
1.3%
272 /1,000
Nexity S.A.
1.2%
378 /1,000
DSM-Firmenich
1.2%
206 /1,000
Skyline Champion Corp
1.2%
353 /1,000
Novozymes
1.2%
212 /1,000
Medibank Private Ltd
1.2%
311 /1,000
Umh Properties Inc.
1.2%
350 /1,000
Ventas Inc.
1.2%
216 /1,000
Persimmon Plc
1.2%
317 /1,000
Idorsia Ltd
1.2%
342 /1,000
Healthpeak Properties Inc.
1.1%
226 /1,000
Intra-Cellular Therapies Inc
1.0%
240 /1,000
Unite Group
0.9%
252 /1,000
Takuma Co Ltd
0.9%
276 /1,000
Sabesp
0.5%
247 /1,000
Grifols
0.3%
262 /1,000
Pennon Group
0.2%
263 /1,000
WELL Health Technologies Corp.
0.2%
266 /1,000
Industrie De Nora S.p.A.
0.1%
266 /1,000
Amalgamated Bank
0.1%
250 /1,000
Benesse Holdings
0.1%
249 /1,000
Beijing Enterprises Water Group
0.1%
237 /1,000
Omega Healthcare Investors Inc.
0.1%
196 /1,000
JD Health International Inc.
0.1%
203 /1,000
Oxford Nanopore Technologies PLC
0.1%
206 /1,000
Sabra Health Care Reit Inc.
0.1%
191 /1,000
Bavarian Nordic A/S
0.1%
195 /1,000
BioArctic AB
0.0%
193 /1,000
Balchem
0.0%
153 /1,000
RWC
0.0%
157 /1,000
Hawkins, Inc.
0.0%
153 /1,000
American Well Corp
0.0%
192 /1,000
United Natural Foods Inc.
0.0%
187 /1,000
The North West Company
0.0%
144 /1,000
ACADIA Pharmaceuticals Inc
0.0%
118 /1,000

As at 24/04/2024

Exposure Breakdown

Geography
USA
45.8%
29 Holdings
India
8.6%
2 Holdings
UK
7.0%
7 Holdings
Germany
7.0%
4 Holdings
France
6.3%
4 Holdings
Sweden
5.2%
4 Holdings
Switzerland
3.8%
2 Holdings
Japan
3.5%
3 Holdings

As at 23/04/2024

Fund Details

Fund AUM
USD 5,026,500
NAV per share
USD 5.03
Number of holdings
72
Ticker (USD)
C5KH
Ticker (GBP)
CKHG
ISIN
IE0001EY64U4
Base Currency
USD
Income Treatment
Accumulating
Inception Date
05/06/2023
Primary Exchange
London Stock Exchange
Total Expense Ratio (TER)
0.49%
Domicile
Ireland
Replication Method
Physical - Full Replication
Index Ticker
ICHWII
Index Provider
BITA GmbH
Issuer
CIRCA5000 ICAV
Promoter
CIRCA5000 UK Ltd
Investment Manager
Vident Advisory, LLC
Custodian
J.P. Morgan SE, Dublin Branch
SFDR Classification
Article 9
UCITS Compliant
Yes
UK Reporting Status
Yes
ISA Eligible
Yes
SIPP Eligible
Yes

Documents

Explore our other funds